DarioHealth Corp (DRIO) USD0.0001
Sell:$0.65Buy:$0.74
$0.03
(4.55%)
- This stock can be held in a
Stocks and Shares ISA$0.03
(4.55%)$0.03
(4.55%)Company Information
About this company
DarioHealth Corp. is a global digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by data analytics, software, and personalized coaching. The Company’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. Its digital therapeutic platform has been designed with a user-first strategy, focusing on the user’s needs and user experience and satisfaction. Dario Blood Glucose Monitoring Starter Kit is a pocket-sized smartphone glucometer that manages diabetes in one ultra-compact device. Dario Blood Pressure Monitoring System is a blood pressure monitoring system used to measure blood pressure, which allows it to store all its user readings in the Dario App. The Dario mobile app is a complete, cloud-based solution for personal chronic condition management.
Key people
Key facts
- EPICDRIO
- LocationUnited States
- SectorHealthcare
- IndustryMedical Equipment & Supplies
- ISINUS23725P2092
- Market cap$29.01m
- Employees196
- Shares in issue43.95m
- ExchangeNASDAQ
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.